Veterinary Medicines Information website

Bovilis Bovipast RSP suspensija injekcijām liellopiem

Authorised
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
Download as PDF

Product identification

Medicine name:
Bovilis Bovipast RSP suspensija injekcijām liellopiem
Active substance:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
    2511890.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    199526000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
    9000000000.00
    cells
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Not specified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/I/26/0029
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Vetzone Limited
Destination wholesaler:
  • Magnum Veterinarija SIA